Auro-Citalopram Tablets
PDF Leaflet Revision Date: 31 October 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of depression, panic disorders, and OCD.
Dosage (summary)
Depression: 20 mg/day, max 60 mg; Panic Disorder: 10 mg/day, increase to 20 mg; OCD: 20 mg/day, max 60 mg.
Onset of Action / Duration
Onset: 2-4 weeks
Special Populations
- Elderly: max 30 mg/day
- Hepatic impairment: halve dose
- Renal impairment: mild/moderate no adjustment
Pregnancy & Breastfeeding
Safety in pregnancy/lactation not established; excreted in breast milk.
Key Drug Interactions
- MAOIs: contraindicated
- Imipramine: increased desimipramine levels
- Serotonergic drugs: risk of serotonin syndrome
- Alcohol: increased effects
- Warfarin: increased anticoagulant activity
- Cimetidine: increased AURO-CITALOPRAM levels
Contraindications
- Hypersensitivity to citalopram
- Concurrent MAOI use
- Severe renal impairment
- Children under 18
Common side effects
- Palpitations
- Sleep disturbances
- Nausea
- Weight changes
- Sexual dysfunction
Counselling Points
- Monitor for suicidal thoughts
- Avoid alcohol
- Gradually taper off when discontinuing
Serious warnings
- Increased risk of seizures
- Monitor for worsening depression/suicidality
- Caution in elderly and hepatic impairment
Important Disclaimer
The Auro-Citalopram Tablets professional information leaflet below is the property of Aurogen South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
